Investigations
Query
Created At
Submitter
René Hänsel8
Project
GLA - German Lymphoma Alliance8
Programme
NHL8
Creator
Marita Ziepert8
8
Investigations visible to you, out of a total of 8
RICOVER-60 is a randomised study comparing 6 and 8 cycles of chemotherapy with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) at 14-day intervals (CHOP-14), both with or without the monoclonal anti-CD20 antibody Rituximab in patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.
Submitter: René Hänsel
Studies: RICOVER-60
Resources: RICOVER-60 trial data, RICOVER-60 trial metadata
No description specified
Submitter: René Hänsel
Studies: SMARTE-R-CHOP-14
Resources: SMARTE-R-CHOP-14 metadata, SMARTE-R-CHOP-14 trial data
No description specified
No description specified
No description specified
Submitter: René Hänsel
Studies: Pegfilgrastim
Resources: Pegfilgrastim metadata, Pegfilgrastim trial data
